NCT04100408View on ClinicalTrials.gov

Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)

Active, not recruitingOBSERVATIONAL
Enrollment

647

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Histiocytosis, Langerhans-Cell
Interventions
OTHER

Biospecimen Collection

Undergo saliva or buccal mucosa collection

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

All Listed Sponsors
lead

Children's Oncology Group

NETWORK